This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Determining the right percentage of income to save for retirement is crucial for millennials. Find out the ideal savings rate for a secure future.
24,766 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Oil is above $100 per barrel for the first time since 2022, and that shift pushes energy costs into the core of AI ec...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
A sharp one-day drop in ZoomInfo’s shares has investors weighing growth against profitability. This analysis explains...
As Ethereum’s core stewardship rethinks its mission, Vitalik Buterin advocates a leaner, more opinionated foundation....
The House Ways and Means Committee plans a June hearing to decide if crypto tax relief should cover more than stablec...
A DXP Enterprises director sold nearly 7,000 shares in a single transaction. This article breaks down the details, ex...
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
A CFO's share sale coincides with bold guidance and a explosive stock rally. This look at what this butterfly network...
Insider moves can tell us a lot about a stock’s near-term path. When Intuitive Machines’ CEO disclosed a $1.39 millio...
Stock moves can be as signaling as they are financial. This article breaks down the factors behind etsy stock popped ...
A private defense contractor is pushing the Navy toward autonomous, unmanned surface ships. This article explains the...